Pliant Therapeutics Inc (PLRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,740 | -37,548 | -123,321 | -88,261 | -57,646 |
| Depreciation Amortization | -5,583 | -2,132 | 17 | 1,104 | 1,357 |
| Accounts receivable | 403 | -1,314 | 15 | 516 | -2,991 |
| Accounts payable and accrued liabilities | 738 | -144 | -1,351 | 254 | 202 |
| Other Working Capital | 3,083 | -3,128 | 4,217 | 10,762 | 3,777 |
| Other Operating Activity | 25,064 | 13,990 | 25,792 | 12,233 | 10,407 |
| Operating Cash Flow | $-55,035 | $-30,276 | $-94,631 | $-63,392 | $-44,894 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -196,420 | -174,045 | -148,444 | -168,632 | 8,924 |
| PPE Investments | -766 | -163 | -1,760 | -1,594 | -898 |
| Investing Cash Flow | $-197,186 | $-174,208 | $-150,204 | $-170,226 | $8,026 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | 9,850 | 10,000 | 10,000 |
| Common Stock Issued | 274,246 | 273,912 | 217,561 | 217,506 | 498 |
| Other Financing Activity | -759 | -586 | -557 | -936 | -225 |
| Financing Cash Flow | $273,487 | $273,326 | $226,854 | $226,570 | $10,273 |
| Beginning Cash Position | 33,685 | 33,685 | 51,665 | 51,665 | 51,665 |
| End Cash Position | 54,951 | 102,527 | 33,684 | 44,617 | 25,070 |
| Net Cash Flow | $21,266 | $68,842 | $-17,981 | $-7,048 | $-26,595 |
| Free Cash Flow | |||||
| Operating Cash Flow | -55,035 | -30,276 | -94,631 | -63,392 | -44,894 |
| Capital Expenditure | -766 | -163 | -1,760 | -1,594 | -898 |
| Free Cash Flow | -55,801 | -30,439 | -96,391 | -64,986 | -45,792 |